JP2000072687A - Alpha-glucosidase inhibitor - Google Patents
Alpha-glucosidase inhibitorInfo
- Publication number
- JP2000072687A JP2000072687A JP10239326A JP23932698A JP2000072687A JP 2000072687 A JP2000072687 A JP 2000072687A JP 10239326 A JP10239326 A JP 10239326A JP 23932698 A JP23932698 A JP 23932698A JP 2000072687 A JP2000072687 A JP 2000072687A
- Authority
- JP
- Japan
- Prior art keywords
- natto
- glucosidase
- glucosidase inhibitor
- tohchi
- temple
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、医薬品、食品、健
康食品、特定保健用食品などに使用することができるト
ウチを有効成分として含有してなるα−グルコシダーゼ
阻害剤に関するものである。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an .alpha.-glucosidase inhibitor comprising as an active ingredient a torch which can be used for pharmaceuticals, foods, health foods, foods for specified health use and the like.
【0002】[0002]
【従来の技術】α−グルコシダーゼ阻害剤は、小腸の微
絨毛に局在するα−グルコシダーゼを阻害し、食後の血
糖値の急上昇及びそれに続くインスリン値の上昇を抑制
することが、Diabate Medicine, 10, 688(1993)に報告
され、人間及び人間以外の動物においても炭水化物(特
に、澱粉由来のオリゴ糖、シュクロース等)の代謝を抑
制するために、例えば血糖上昇抑制作用を示し、過血糖
症状及び過血糖に由来する肥満症、糖尿病などの種々の
疾患の改善に有用である。また、α−グルコシダーゼ阻
害剤を添加して製造した(健康)食品は、代謝異常の患
者食に適しており、さらに代謝異常予防食として健康な
人にも適している。BACKGROUND OF THE INVENTION α- glucosidase inhibitors, inhibit α- glucosidase localized in microvilli of the small intestine, to suppress spikes and elevated insulin levels subsequent postprandial blood glucose, Diabate Medicine, 10 , 688 (1993). In humans and non-human animals, it shows an inhibitory effect on carbohydrates (especially, starch-derived oligosaccharides, sucrose, etc.). And it is useful for improvement of various diseases such as obesity and diabetes caused by hyperglycemia. In addition, (healthy) foods produced by adding an α-glucosidase inhibitor are suitable for a diet for patients with metabolic disorders, and are also suitable for healthy persons as a diet for preventing metabolic disorders.
【0003】食品に由来するα−グルコシダーゼ阻害剤
としては、例えば、特開平9−65836号公報には、
動物性蛋白質又は植物性蛋白質の酵素加水分解物が開示
され、特開平5−17364号公報には茶ポリフェノー
ルが開示されている。[0003] As an α-glucosidase inhibitor derived from food, for example, Japanese Patent Application Laid-Open No. 9-65836 discloses
An enzyme hydrolyzate of an animal protein or a vegetable protein is disclosed, and Japanese Patent Application Laid-Open No. 5-17364 discloses a tea polyphenol.
【0004】[0004]
【発明が解決しようとする課題】しかしながら、上記特
開平9−65836号公報に記載のα−グルコシダ一ゼ
阻害剤は、活性を示すためには食品として大量に摂取し
なくてはならず、また、特開平5−17364号公報開
示技術では、ポリフェノールの精製が煩雑であり、かつ
通常摂取する茶ではやはり多量に摂取する必要があっ
た。本発明では、α−グルコシダ一ゼ阻害活性が強く、
かつ摂取も容易な優れたα−グルコシダーゼ阻害剤を提
供することを目的とするものである。However, the α-glucosidase inhibitor described in Japanese Patent Application Laid-Open No. 9-65836 must be ingested in large quantities as a food in order to exhibit its activity. According to the technology disclosed in Japanese Patent Application Laid-Open No. Hei 5-17364, purification of polyphenol is complicated, and it is necessary to ingest a large amount of tea which is usually taken. In the present invention, α-glucosidase inhibitory activity is strong,
An object of the present invention is to provide an excellent α-glucosidase inhibitor which is easy to ingest.
【0005】[0005]
【課題を解決するための手段】本発明者は、鋭意検討を
行った結果、中華料理の食材としても用いられているト
ウチ(豆鼓)が、強いα−グルコシダーゼ阻害活性を有
するということを見いだし本発明を完成するに至った。Means for Solving the Problems As a result of intensive studies, the present inventor has found that touchi (bean drum), which is also used as an ingredient in Chinese cuisine, has a strong α-glucosidase inhibitory activity. The present invention has been completed.
【0006】本発明のトウチは中華料理の食材として一
般に市販されているもので、通常蒸した大豆をこうじで
発酵させたものであり、日本の大徳寺納豆、浜納豆、寺
納豆、塩から納豆、一休寺納豆等の納豆も本発明のトウ
チに含まれる。The torch of the present invention is generally commercially available as an ingredient for Chinese cuisine, and is usually made by fermenting steamed soybeans with koji, and is used to make natto from Daitokuji natto, Hama natto, Tera natto, and salt. Also, natto such as Ikkyuji natto is included in the present invention.
【0007】トウチは、通常の形態で用いられ、更に乾
燥させて粉末化したり、水中で粉砕し、スラリー状にし
たものでもグルコシダーゼ阻害活性を示すが、水及び/
又はアルコールでの抽出物がより強いα−グルコシダー
ゼ阻害活性が得られるので好ましく、更には水及びアル
コールの混合液での抽出物が好ましい。該アルコールと
してはメタノール、エタノール、プロパノール、ブタノ
ール等が挙げられるがエタノールが好ましい。抽出法と
しては、加熱抽出、連続抽出、浸漬、超臨界抽出などの
抽出方法を使用してもよい。水/アルコールの混合比
(重量比)としては、1/100〜100/1が好まし
く、更には、1/50〜50/1である。[0007] The torch is used in a usual form, and it is further dried to be powdered or pulverized in water to form a slurry, but shows glucosidase inhibitory activity.
Alternatively, an extract with an alcohol is preferable because a stronger α-glucosidase inhibitory activity is obtained, and an extract with a mixture of water and an alcohol is more preferable. Examples of the alcohol include methanol, ethanol, propanol, and butanol, but ethanol is preferred. As the extraction method, an extraction method such as heat extraction, continuous extraction, immersion, and supercritical extraction may be used. The mixing ratio (weight ratio) of water / alcohol is preferably from 1/100 to 100/1, and more preferably from 1/50 to 50/1.
【0008】抽出法として具体的には、トウチを粉砕
し、この粉末を等重量の水及びアルコールの混合液(水
/アルコールの重量比=1/1)に浸漬して加熱し、1
0〜30分間沸騰させることにより、有効成分を抽出す
ることができる。また、トウチを等重量の水及びアルコ
ールの混合液に浸し、室温で5時間〜7日放置、もしく
は、40〜60℃で12〜18時間程度加熱することに
より、有効成分を抽出することができる。More specifically, as an extraction method, a torch is crushed, and this powder is immersed in an equal weight mixture of water and alcohol (weight ratio of water / alcohol = 1/1) and heated.
By boiling for 0 to 30 minutes, the active ingredient can be extracted. In addition, the active ingredient can be extracted by immersing the torch in an equal weight mixture of water and alcohol and leaving it at room temperature for 5 hours to 7 days, or heating it at 40 to 60 ° C. for about 12 to 18 hours. .
【0009】上記の水及び/又はアルコール抽出物は、
水及び/又はアルコールを留去すれば粉末となり、これ
をα−グルコシダーゼ阻害剤として用いることが好まし
い。さらに、少量の摂取で効果を挙げるために、該抽出
物をメタノール、エタノール、プロパノール、ブタノー
ル、クロロホルム、酢酸エチル、トルエン、ヘキサン、
ベンゼンなどの極性有機溶媒を用いた溶媒分画操作によ
って有効成分を濃縮し、更にアルミナカラムクロマトグ
ラフィー、シリカゲルカラムクロマトグラフィー、ゲル
ろ過クロマトグラフィー、イオン交換クロマトグラフィ
ー、疎水クロマトグラフイー、高速液体クロマトグラフ
ィーなどの適当な分離精製を1種あるいは数種を組合わ
せることにより精製することもできる。The above-mentioned water and / or alcohol extract is
If water and / or alcohol is distilled off, a powder is obtained, which is preferably used as an α-glucosidase inhibitor. Further, in order to improve the effect of small ingestion, the extract is methanol, ethanol, propanol, butanol, chloroform, ethyl acetate, toluene, hexane,
The active ingredient is concentrated by a solvent fractionation operation using a polar organic solvent such as benzene, and then further subjected to alumina column chromatography, silica gel column chromatography, gel filtration chromatography, ion exchange chromatography, hydrophobic chromatography, and high performance liquid chromatography. Purification can also be carried out by appropriate separation and purification such as described above, or by combining one or several kinds.
【0010】本発明のα−グルコシダーゼ阻害剤は、血
糖上昇抑制作用を有しているので水、エタノール、エチ
レングリコール、ポリエチレングリコールなどの液状担
体や、でんぷん、セルロース、ポリアミド粉末などの固
形担体などの無毒性担体で希釈して、アンプル剤、顆粒
剤、錠剤、丸剤、カプセル剤、シロップ剤などの医薬
品、健康食品として代謝異常の患者食又は予防薬、糖尿
病、肥満症の予防薬として用いることができる。さら
に、本発明のα−グルコシダーゼ阻害剤を含有する上記
製剤を、食前、食中、食後、食間などに服用することに
より、喫食による血糖濃度の増加を抑制することができ
る。[0010] The α-glucosidase inhibitor of the present invention has a blood glucose elevation inhibitory action, and is therefore suitable for liquid carriers such as water, ethanol, ethylene glycol and polyethylene glycol, and solid carriers such as starch, cellulose and polyamide powder. Diluted with a non-toxic carrier, and used as pharmaceuticals such as ampoules, granules, tablets, pills, capsules and syrups, as health foods, as a diet or prophylactic for patients with metabolic disorders, as a preventive for diabetes and obesity Can be. Furthermore, by taking the above-mentioned preparation containing the α-glucosidase inhibitor of the present invention before, during, after or between meals, an increase in blood glucose concentration due to eating can be suppressed.
【0011】このときの人の摂取量としては、トウチの
乾燥粉末として、0.1〜50g/日が好ましく、特に
0.5〜10g/日が好ましい。 水及び/又はアルコ
ール抽出物あるいは、上記で述べた単離化合物を用いる
場合、該乾燥粉末の1/1000〜1/10の摂取量で
もよい。The amount of human consumption at this time is preferably 0.1 to 50 g / day, particularly preferably 0.5 to 10 g / day, as a dry powder of torch. When using water and / or alcohol extracts or the above-mentioned isolated compounds, the intake may be 1/1000 to 1/10 of the dry powder.
【0012】本発明のα−グルコシターゼ阻害剤は、食
品に添加することも可能で、例えば、コーヒー、果汁、
清涼飲料水、ビール、牛乳、味噌汁、スープ、紅茶、
茶、栄養剤、シロップ、マーガリン、ジャムなどの液状
(流動状)食品、米飯、パン、じゃがいも製品、もち、
飴、チョコレート、ふりかけ、ハム、ソーセージ、キャ
ンディーなどの固形形状食品などの主食、 副食、 菓子
類ならびに調味料に添加することも可能である。このと
きの添加量としては、上記食品に対して、トウチの乾燥
粉末として、0.001〜85重量%が好ましく、特に
0.01〜60重量%が好ましい。水及び/又はアルコ
ール抽出物を用いる場合、該乾燥粉末の1/1000〜
1/10(重量比)の添加量でもよい。また、食品の場
合も摂取量は、上記で述べた医薬品、健康食品と同様が
好ましく、更に本発明の効果を阻害しない範囲で、甘味
剤、保存剤、分散剤、着色剤、酸化防止剤等も併用する
ことができる。更に、その他の公知のα−グルコシダー
ゼ阻害剤であるバリエナミンやアミノシクリトールなど
のα−グルコシダ一ゼ阻害剤と併用してもよい。The α-glucosidase inhibitor of the present invention can be added to foods, for example, coffee, fruit juice,
Soft drink, beer, milk, miso soup, soup, tea,
Liquid (fluid) foods such as tea, nutrients, syrup, margarine, jam, rice, bread, potato products, rice cake,
It can also be added to staple foods, side dishes, confectionery and seasonings such as candy, chocolate, sprinkle, ham, sausage, candy and other solid foods. The addition amount at this time is preferably 0.001 to 85% by weight, particularly preferably 0.01 to 60% by weight, as a dry powder of torch, based on the food. When using water and / or alcohol extract, 1/1000 of the dry powder
The addition amount may be 1/10 (weight ratio). In addition, in the case of foods, the intake amount is preferably the same as the above-mentioned pharmaceuticals and health foods, and furthermore, a sweetener, a preservative, a dispersant, a coloring agent, an antioxidant and the like within a range that does not inhibit the effects of the present invention. Can also be used in combination. Further, it may be used in combination with other known α-glucosidase inhibitors such as varienamine and aminocyclitol which are α-glucosidase inhibitors.
【0013】[0013]
【実施例】以下本発明について具体的に説明する。尚、
以下の記述で「%」とあるのは重量%である。 実施例1 乾燥したトウチ1kgを10lの50%メタノール水溶
液に1日浸漬し、 得られた浸漬液をロータリーエバポ
レーターで濃縮し、これを水に溶解した後、ろ過した。
得られたろ液を減圧濃縮し、抽出液(E−1)を得た。
該抽出液をロータリーエバポレーターで乾固し、193
gの固形物を得た。該固形物を分液漏斗に入れて、酢酸
エチル/水(容量比=1/2)の混合溶液を固形分の1
〜10倍重量加えて、水層(E−2)、酢酸エチル層
(E−3)をそれぞれの分画し、α−グルコシダーゼ阻
害活性の測定をした。それぞれの画分(E−1、E−
2、E−3)のα−グルコシダーゼ阻害活性は以下のよ
うに測定した。The present invention will be specifically described below. still,
In the following description, "%" means% by weight. Example 1 1 kg of dried touch was immersed in 10 l of a 50% aqueous methanol solution for 1 day, and the obtained immersion liquid was concentrated by a rotary evaporator, dissolved in water, and filtered.
The obtained filtrate was concentrated under reduced pressure to obtain an extract (E-1).
The extract was evaporated to dryness on a rotary evaporator and 193
g of solid was obtained. The solid was put into a separatory funnel, and a mixed solution of ethyl acetate / water (volume ratio = 1/2) was mixed with one part of the solid.
The aqueous layer (E-2) and the ethyl acetate layer (E-3) were fractionated by adding 10 to 10 times the weight, and the α-glucosidase inhibitory activity was measured. Each fraction (E-1, E-
2. The α-glucosidase inhibitory activity of E-3) was measured as follows.
【0014】(1) ラット小腸からの二(三)糖加水
分解酵素(α−グルコシダーゼ)の調製 冷凍保存しておいたラット小腸(空腸)を解凍し、粘膜
をピンセットで押出すように採取した。該粘膜に5倍重
量の5mMエチレンジアミン四酢酸を含む0.1Mリン
酸カリウム緩衝液(pH7.0)を加え、冷却しながら
ホモゲナイズした。その後遠心分離(4℃、21000
×g、60分)し、得られた沈殿物に5倍重量になるよ
うに1%トリトンX−100を含む0.1Mリン酸カリ
ウム緩衝液(pH7.0)を加え、可溶化処理(4℃、
60分)を行った。これを超遠心分離(4℃、1100
00×g、90分)し、この上清を0.01Mリン酸カ
リウム緩衝液(pH7.0)で透析(4℃、24時間)
し、酵素液とした。(1) Preparation of di (tri) sugar hydrolase (α-glucosidase) from rat small intestine The frozen small rat intestine (jejunum) was thawed, and the mucous membrane was extruded using forceps. . A 0.1 M potassium phosphate buffer (pH 7.0) containing 5 times the weight of 5 mM ethylenediaminetetraacetic acid was added to the mucous membrane, and homogenized while cooling. Thereafter, centrifugation (4 ° C., 21000
× g, 60 minutes), and a 0.1 M potassium phosphate buffer (pH 7.0) containing 1% Triton X-100 was added to the obtained precipitate so as to have a 5-fold weight, and solubilization treatment (4 ℃,
60 minutes). This is ultracentrifuged (4 ° C, 1100
00 × g, 90 minutes), and the supernatant is dialyzed against 0.01 M potassium phosphate buffer (pH 7.0) (4 ° C., 24 hours)
And used as an enzyme solution.
【0015】(2)酵素(α−グルコシダーゼ)活性の
測定 酵素活性は市販のキットを用い、基質としてはシュクロ
ースを用いた。標準反応液組成は、60mM基質溶液
(シュクロースを0.1Mリン酸カリウム緩衝液pH
6.3に溶解してたもの)0.7ml、被験物質溶液
(それぞれの分画成分の水、有機溶剤を完全に除去した
後、50%ジメチルスルホキシド水溶液に溶解)0.2
ml、上記酵素液0.1ml(計1.0ml)とした。
これを37℃、15分間反応させ、2Mトリス塩酸緩衝
液(pH7.0)1.5mlを用いて反応を停止させ試
験液とした。尚、反応液中の被験物の濃度は、20mg
/mlとした。次に96穴マイクロプレートに1穴あた
り発色試薬〔グルコースBテストワコー(和光純薬
製)〕200μlに試験液50μl(酢酸エチル等は留
去したもの)を加え、37℃で30分間インキュベート
した後、マイクロプレートリーダ(BIO RAD社
製、MODEL550)で490nmの吸光度を測定し
た。基質溶液の代りに0.1Mリン酸カリウム緩衝液
(pH6.3)を加えた時の吸光度をブランク値とし、
この値を差し引いた値をA490sとした。被験液の代りに
50重量%ジメチルスルホキシド水溶液を加えた時の吸
光度をコントロール値(A 490c)とし、下式によりα−
グルコシダーゼ阻害活性を求めた。測定は2回行い、平
均値を測定値とした。(2) Enzyme (α-glucosidase) activity
Measurement Enzyme activity was measured using a commercially available kit.
Source was used. Standard reaction solution composition is 60 mM substrate solution
(Sucrose in 0.1 M potassium phosphate buffer pH
0.7 ml, dissolved in 6.3), test substance solution
(The water and organic solvent of each fraction were completely removed.
And then dissolved in a 50% aqueous solution of dimethyl sulfoxide) 0.2
ml, and the above enzyme solution was 0.1 ml (1.0 ml in total).
This was reacted at 37 ° C. for 15 minutes, and then buffered with 2 M Tris-HCl buffer.
Stop the reaction using 1.5 ml of the solution (pH 7.0)
The test solution was used. The concentration of the test substance in the reaction solution was 20 mg.
/ Ml. Next, one hole was placed on a 96-well microplate.
Recoloring reagent [Glucose B Test Wako (Wako Pure Chemical Industries, Ltd.)
50 μl of test solution in 200 μl (ethyl acetate, etc.
Removed) and incubate at 37 ° C for 30 minutes
And then a microplate reader (BIO RAD)
Absorbance at 490 nm with Model 550)
Was. 0.1 M potassium phosphate buffer instead of substrate solution
The absorbance when (pH 6.3) was added was taken as a blank value,
The value obtained by subtracting this value is A490sAnd Instead of test liquid
Absorption when adding 50% by weight aqueous solution of dimethyl sulfoxide
Control the brightness (A 490c), And α-
Glucosidase inhibitory activity was determined. The measurement is performed twice,
The average was taken as the measured value.
【0016】[0016]
【数1】α−グルコシダーゼ阻害活性(%)={(A490c
−A490s)/A490c}×100 それぞれの画分(E−1、E−2、E−3)のα−グル
コシダーゼ阻害活性を表1に示した。Α-glucosidase inhibitory activity (%) = {(A 490c
−A 490s ) / A 490c } × 100 The α-glucosidase inhibitory activity of each fraction (E-1, E-2, E-3) is shown in Table 1.
【0017】[0017]
【表1】 * :それぞれの分画成分を濃縮乾固して重量を求め、
乾燥した原料の重量に対する値とした。[Table 1] *: Each fraction was concentrated to dryness to determine the weight,
The value was based on the weight of the dried raw material.
【0018】[0018]
【発明の効果】本発明のグルコシダーゼ阻害剤はトウチ
を有効成分として含有するので、摂取し易く、強い阻害
活性を示す。Industrial Applicability The glucosidase inhibitor of the present invention contains torch as an active ingredient and is easy to ingest and exhibits a strong inhibitory activity.
Claims (2)
特徴とするα−グルコシダーゼ阻害剤。1. An α-glucosidase inhibitor comprising touchi as an active ingredient.
ルコール抽出物を用いることを特徴とする請求項1記載
のα−グルコシダーゼ阻害剤。2. The α-glucosidase inhibitor according to claim 1, wherein a water and / or alcohol extract of the torch is used as the torch.
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10239326A JP2000072687A (en) | 1998-08-26 | 1998-08-26 | Alpha-glucosidase inhibitor |
US09/530,063 US6299911B1 (en) | 1998-08-26 | 1999-08-20 | Extract of Touchi containing an α-glucosidase inhibitor |
DE69903911T DE69903911T2 (en) | 1998-08-26 | 1999-08-20 | alpha-GLUCOSIDASE HEMMER |
PCT/JP1999/004466 WO2000012109A1 (en) | 1998-08-26 | 1999-08-20 | α-GLUCOSIDASE INHIBITOR |
CNB998014648A CN1170550C (en) | 1998-08-26 | 1999-08-20 | Alpha-glucosidase inhibitor |
EP99938534A EP1025851B1 (en) | 1998-08-26 | 1999-08-20 | Alpha-glucosidase inhibitor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10239326A JP2000072687A (en) | 1998-08-26 | 1998-08-26 | Alpha-glucosidase inhibitor |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2000072687A true JP2000072687A (en) | 2000-03-07 |
Family
ID=17043066
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10239326A Pending JP2000072687A (en) | 1998-08-26 | 1998-08-26 | Alpha-glucosidase inhibitor |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2000072687A (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002027981A (en) * | 2000-07-14 | 2002-01-29 | Nippon Synthetic Chem Ind Co Ltd:The | Method for producing alpha-glucosidase inhibitor |
JP2002027979A (en) * | 2000-07-14 | 2002-01-29 | Nippon Synthetic Chem Ind Co Ltd:The | Method for producing alpha-glucosidase inhibitor |
JP2002027978A (en) * | 2000-07-14 | 2002-01-29 | Nippon Synthetic Chem Ind Co Ltd:The | Method for producing alpha-glucosidase inhibitor |
JP2002027980A (en) * | 2000-07-14 | 2002-01-29 | Nippon Synthetic Chem Ind Co Ltd:The | Method for producing alpha-glucosidase inhibitor |
JP2006296251A (en) * | 2005-04-19 | 2006-11-02 | Gunze Ltd | alpha-GLUCOSIDASE INHIBITOR |
JP2009538342A (en) * | 2006-05-26 | 2009-11-05 | ネステク ソシエテ アノニム | Method for using touchi extract and nutritional composition |
WO2011016220A1 (en) * | 2009-08-03 | 2011-02-10 | 株式会社カネカ | Dipeptidyl peptidase-4 inhibitor |
WO2011104971A1 (en) * | 2010-02-25 | 2011-09-01 | 富士フイルム株式会社 | Composition for controlling weight gain and food product containing the same |
JP2012171923A (en) * | 2011-02-22 | 2012-09-10 | Kao Corp | Ppar-activating agent |
CN103169075A (en) * | 2011-12-21 | 2013-06-26 | 光明乳业股份有限公司 | Fermented bean product fermented by lactobacillus plantarum ST-III and alpha-glucosidase inhibitor |
-
1998
- 1998-08-26 JP JP10239326A patent/JP2000072687A/en active Pending
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002027979A (en) * | 2000-07-14 | 2002-01-29 | Nippon Synthetic Chem Ind Co Ltd:The | Method for producing alpha-glucosidase inhibitor |
JP2002027978A (en) * | 2000-07-14 | 2002-01-29 | Nippon Synthetic Chem Ind Co Ltd:The | Method for producing alpha-glucosidase inhibitor |
JP2002027980A (en) * | 2000-07-14 | 2002-01-29 | Nippon Synthetic Chem Ind Co Ltd:The | Method for producing alpha-glucosidase inhibitor |
JP2002027981A (en) * | 2000-07-14 | 2002-01-29 | Nippon Synthetic Chem Ind Co Ltd:The | Method for producing alpha-glucosidase inhibitor |
JP4738571B2 (en) * | 2000-07-14 | 2011-08-03 | 日本サプリメント株式会社 | Method for producing α-glucosidase inhibitor |
JP2006296251A (en) * | 2005-04-19 | 2006-11-02 | Gunze Ltd | alpha-GLUCOSIDASE INHIBITOR |
US8815312B2 (en) | 2006-05-26 | 2014-08-26 | Nestec S.A. | Methods of use and nutritional compositions of Touchi Extract |
JP2009538342A (en) * | 2006-05-26 | 2009-11-05 | ネステク ソシエテ アノニム | Method for using touchi extract and nutritional composition |
WO2011016220A1 (en) * | 2009-08-03 | 2011-02-10 | 株式会社カネカ | Dipeptidyl peptidase-4 inhibitor |
JP5916387B2 (en) * | 2009-08-03 | 2016-05-11 | 株式会社カネカ | Dipeptidyl peptidase-4 inhibitor |
US9399051B2 (en) | 2009-08-03 | 2016-07-26 | Kaneka Corporation | Dipeptidyl peptidase-4 inhibitor |
WO2011104971A1 (en) * | 2010-02-25 | 2011-09-01 | 富士フイルム株式会社 | Composition for controlling weight gain and food product containing the same |
JP2012171923A (en) * | 2011-02-22 | 2012-09-10 | Kao Corp | Ppar-activating agent |
CN103169075A (en) * | 2011-12-21 | 2013-06-26 | 光明乳业股份有限公司 | Fermented bean product fermented by lactobacillus plantarum ST-III and alpha-glucosidase inhibitor |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103443112B (en) | Saccharide condensation polymer, its manufacture method and application thereof | |
EP2156751B1 (en) | Novel sweetener having sugar-like taste and production method and use of the same | |
KR101838113B1 (en) | Method for producing sugar composition containing definite amount of target hexose and having sugar composition ratio different from starting sugar material, and use of sugar composition thus produced | |
KR101974975B1 (en) | Composition for improving in vivo metabolism parameter | |
JP2011205913A (en) | Complex crystalline sugar of functional isomerized sugar and method for producing the same | |
JP2000072687A (en) | Alpha-glucosidase inhibitor | |
JP3510717B2 (en) | Foods and beverages with active oxygen and free radical scavenging activity | |
US8231911B2 (en) | Serum uric acid level-decreasing agent and food and drink with label telling that food and drink decrease serum uric acid level | |
JP2000072682A (en) | Alpha-glucosidase inhibitor | |
EP1025851B1 (en) | Alpha-glucosidase inhibitor | |
JP4865955B2 (en) | α-Glucosidase inhibitor, method for producing food or feed, and method for producing additive | |
JP2000229867A (en) | Alpha-glucosidase inhibitor | |
JP2000229869A (en) | Alpha-glucosidase inhibitor | |
JP2000229874A (en) | Alpha-glucosidase inhibitor | |
JP4795512B2 (en) | Method for producing α-glucosidase inhibitor | |
JP2000229875A (en) | Alpha-glucosidase inhibitor | |
JP2000229873A (en) | Alpha-glucosidase inhibitor | |
JPH03240464A (en) | Healthy food containing dioscorea japonica thumb extract | |
JP2000229868A (en) | Alpha-glucosidase inhibitor | |
JPH0948736A (en) | Alpha-glucosidase inhibitor | |
JP3911366B2 (en) | α-Glucosidase inhibitor | |
JP2003095941A (en) | Sugar digestion enzyme inhibitor, hyperglycemia inhibitor, therapeutic or prophylactic agent for obesity, therapeutic or prophylactic agent for diabetes, and healthy food and drink | |
JP4795511B2 (en) | Method for producing α-glucosidase inhibitor | |
JP2002053475A (en) | Glucosidase inhibitor and food or beverage including the same | |
KR100270292B1 (en) | Beverage with extracts of ganoderma and onions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20060621 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20060621 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20060622 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060919 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20061117 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20061226 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070223 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070412 |
|
A911 | Transfer of reconsideration by examiner before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20070417 |